These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

280 related items for PubMed ID: 3463410

  • 1. Glutathione depletion as a determinant of sensitivity of human leukemia cells to cyclophosphamide.
    Crook TR, Souhami RL, Whyman GD, McLean AE.
    Cancer Res; 1986 Oct; 46(10):5035-8. PubMed ID: 3463410
    [Abstract] [Full Text] [Related]

  • 2. Cytotoxicity, DNA cross-linking, and single strand breaks induced by activated cyclophosphamide and acrolein in human leukemia cells.
    Crook TR, Souhami RL, McLean AE.
    Cancer Res; 1986 Oct; 46(10):5029-34. PubMed ID: 3463409
    [Abstract] [Full Text] [Related]

  • 3. Depletion of cellular glutathione by N,N'-bis(trans-4-hydroxycyclohexyl)-N'-nitrosourea as a determinant of sensitivity of K562 human leukemia cells to 4-hydroperoxycyclophosphamide.
    Chresta CM, Crook TR, Souhami RL.
    Cancer Res; 1990 Jul 01; 50(13):4067-71. PubMed ID: 2354456
    [Abstract] [Full Text] [Related]

  • 4. Role of glutathione in the in vitro synergism between 4-hydroperoxy-cyclophosphamide and cisplatin in leukemia cell lines.
    Peters RH, Jollow DJ, Stuart RK.
    Cancer Res; 1991 May 15; 51(10):2536-41. PubMed ID: 2021933
    [Abstract] [Full Text] [Related]

  • 5. Buthionine sulfoximine induction of gamma-L-glutamyl-L-cysteine synthetase gene expression, kinetics of glutathione depletion and resynthesis, and modulation of carmustine-induced DNA-DNA cross-linking and cytotoxicity in human glioma cells.
    Ali-Osman F, Antoun G, Wang H, Rajagopal S, Gagucas E.
    Mol Pharmacol; 1996 Jun 15; 49(6):1012-20. PubMed ID: 8649339
    [Abstract] [Full Text] [Related]

  • 6. Relationship of DNA damage and embryotoxicity induced by 4-hydroperoxydechlorocyclophosphamide in postimplantation rat embryos.
    Little SA, Mirkes PE.
    Teratology; 1990 Feb 15; 41(2):223-31. PubMed ID: 2321166
    [Abstract] [Full Text] [Related]

  • 7. Glutathione and related enzymes in rat brain tumor cell resistance to 1,3-bis(2-chloroethyl)-1-nitrosourea and nitrogen mustard.
    Evans CG, Bodell WJ, Tokuda K, Doane-Setzer P, Smith MT.
    Cancer Res; 1987 May 15; 47(10):2525-30. PubMed ID: 2882834
    [Abstract] [Full Text] [Related]

  • 8. Cyclophosphamide resistance in medulloblastoma.
    Friedman HS, Colvin OM, Kaufmann SH, Ludeman SM, Bullock N, Bigner DD, Griffith OW.
    Cancer Res; 1992 Oct 01; 52(19):5373-8. PubMed ID: 1356617
    [Abstract] [Full Text] [Related]

  • 9. Upregulation of cellular glutathione by 3H-1,2-dithiole-3-thione as a possible treatment strategy for protecting against acrolein-induced neurocytotoxicity.
    Jia Z, Misra BR, Zhu H, Li Y, Misra HP.
    Neurotoxicology; 2009 Jan 01; 30(1):1-9. PubMed ID: 19073213
    [Abstract] [Full Text] [Related]

  • 10. Glutathione depletion by L-buthionine sulfoximine antagonizes taxol cytotoxicity.
    Liebmann JE, Hahn SM, Cook JA, Lipschultz C, Mitchell JB, Kaufman DC.
    Cancer Res; 1993 May 01; 53(9):2066-70. PubMed ID: 8097674
    [Abstract] [Full Text] [Related]

  • 11. Cytotoxicity and DNA cross-linking activity of 4-sulfidocyclophosphamides in mouse leukemia cells in vitro.
    Erickson LC, Ramonas LM, Zaharko DS, Kohn KW.
    Cancer Res; 1980 Nov 01; 40(11):4216-20. PubMed ID: 7471062
    [Abstract] [Full Text] [Related]

  • 12. Effect of buthionine sulfoximine and ethacrynic acid on cytotoxic activity of mitomycin C analogues BMY 25282 and BMY 25067.
    Xu BH, Singh SV.
    Cancer Res; 1992 Dec 01; 52(23):6666-70. PubMed ID: 1423311
    [Abstract] [Full Text] [Related]

  • 13. The role of DNA damage in the resistance of human chronic myeloid leukemia cells to cyclophosphamide analogues.
    Andersson BS, Mroue M, Britten RA, Murray D.
    Cancer Res; 1994 Oct 15; 54(20):5394-400. PubMed ID: 7923171
    [Abstract] [Full Text] [Related]

  • 14. Effect of acrolein on phosphoramide mustard-induced sister chromatid exchanges in cultured human lymphocytes.
    Wilmer JL, Erexson GL, Kligerman AD.
    Cancer Res; 1990 Aug 01; 50(15):4635-8. PubMed ID: 2369740
    [Abstract] [Full Text] [Related]

  • 15. DNA damage in cyclophosphamide-resistant tumor cells: the role of glutathione.
    Richardson ME, Siemann DW.
    Cancer Res; 1995 Apr 15; 55(8):1691-5. PubMed ID: 7712476
    [Abstract] [Full Text] [Related]

  • 16. Effects of glutathione depletion by buthionine sulfoximine on radiosensitization by oxygen and misonidazole in vitro.
    Shrieve DC, Denekamp J, Minchinton AI.
    Radiat Res; 1985 Jun 15; 102(3):283-94. PubMed ID: 4070545
    [Abstract] [Full Text] [Related]

  • 17. Modulation of glutathione level in cultured human melanoma cells.
    Karg E, Brötell H, Rosengren E, Rorsman H.
    Acta Derm Venereol; 1989 Jun 15; 69(2):137-41. PubMed ID: 2564231
    [Abstract] [Full Text] [Related]

  • 18. Mitomycin C sensitivity in human bladder cancer cells: possible role of glutathione and glutathione transferase in resistance.
    Xu BH, Gupta V, Singh SV.
    Arch Biochem Biophys; 1994 Jan 15; 308(1):164-70. PubMed ID: 8311448
    [Abstract] [Full Text] [Related]

  • 19. Differential potentiation of alkylating and platinating agent cytotoxicity in human ovarian carcinoma cells by glutathione depletion.
    Andrews PA, Murphy MP, Howell SB.
    Cancer Res; 1985 Dec 15; 45(12 Pt 1):6250-3. PubMed ID: 4063975
    [Abstract] [Full Text] [Related]

  • 20. Glutathione depletion by DL-buthionine-SR-sulfoximine (BSO) potentiates X-ray-induced chromosome lesions after liquid holding recovery.
    Bertsche U, Schorn H.
    Radiat Res; 1986 Mar 15; 105(3):351-69. PubMed ID: 3754339
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.